Global Counterfeit Drugs and CAR-T Scams: How Gray Market Channels Threaten Cancer Patient Safety

How counterfeit drugs, gray market channels, and unverified CAR-T services are creating growing risks for global cancer patients and why supply chain transparency matters more than ever.

Top Stories

Latest Coverage

Counterfeit Cancer Drugs, Weight-Loss Medications, and ED Pills: The Growing Global Threat to Patient Safety
The global pharmaceutical industry has achieved remarkable breakthroughs over the last decade. From targeted oncology...
Eli Lilly’s Retatrutide Phase 3 Data Shocks the Market: Behind the 30% Weight Loss, the Peptide API Supply Chain Emerges as a New Hotspot
On May 21, Eli Lilly and Company announced positive topline results from the Phase 3 TRIUMPH-1 clinical trial of its ...
How AI Reshapes Drug R&D: A Full-Chain Innovation from Target Discovery to Clinical Trials
As global pharmaceutical innovation gradually enters a stage of high complexity and high investment, traditional drug...
A Breakthrough in Nebulized Antiviral Therapy: Phase III Progress of Peramivir Inhalation Solution
In the field of influenza treatment, traditional therapies have long relied on oral and intravenous administration ro...

In-Depth Analysis


This site uses Just the Docs, a documentation theme for Jekyll.